Answer questions and earn CME/CNE The American Cancer Society Head and Neck Cancer Survivorship Care Guideline was developed to assist primary care clinicians and other health practitioners with the care of head and neck cancer survivors, including monitoring for recurrence, screening for second primary cancers, assessment and management of long-term and late effects, health promotion, and care coordination. A systematic review of the literature was conducted using PubMed through April 2015, and a multidisciplinary expert workgroup with expertise in primary care, dentistry, surgical oncology, medical oncology, radiation oncology, clinical psychology, speech-language pathology, physical medicine and rehabilitation, the patient perspective, and nursing was assembled. While the guideline is based on a systematic review of the current literature, most evidence is not sufficient to warrant a strong recommendation. Therefore, recommendations should be viewed as consensus-based management strategies for assisting patients with physical and psychosocial effects of head and neck cancer and its treatment. CA Cancer J Clin 2016;66:203-239. © 2016 American Cancer Society.

https://www.wileyhealthlearning.com/acs.aspx Prostate cancer survivors approach 2.8 million in number and represent 1 in 5 of all cancer survivors in the United States. While guidelines exist for timely treatment and surveillance for recurrent disease, there is limited availability of guidelines that facilitate the provision of posttreatment clinical follow‐up care to address the myriad of long‐term and late effects that survivors may face. Based on recommendations set forth by a National Cancer Survivorship Resource Center expert panel, the American Cancer Society developed clinical follow‐up care guidelines to facilitate the provision of posttreatment care by primary care clinicians. These guidelines were developed using a combined approach of evidence synthesis and expert consensus. Existing guidelines for health promotion, surveillance, and screening for second primary cancers were referenced when available. To promote comprehensive follow‐up care and optimal health and quality of life for the posttreatment survivor, the guidelines address health promotion, surveillance for prostate cancer recurrence, screening for second primary cancers, long‐term and late effects assessment and management, psychosocial issues, and care coordination among the oncology team, primary care clinicians, and nononcology specialists. A key challenge to the development of these guidelines was the limited availability of published evidence for management of prostate cancer survivors after treatment. Much of the evidence relies on studies with small sample sizes and retrospective analyses of facility‐specific and population databases. CA Cancer J Clin 2014;64:225–249. © 2014 American Cancer Society.

Colorectal cancer (CRC) is the third most common malignant disease in the United States (U.S.). Almost two-thirds of CRC survivors are living 5 years following diagnosis. The prevalence of CRC survivors is likely to increase dramatically over the coming decades with further advances in early detection and treatment and the aging and growth of the U.S. population. Survivors are at risk for a CRC recurrence, a new primary CRC, other cancers, as well as both short and long-term adverse effects of the CRC and the modalities used to treat it. CRC survivors may also have psychological, reproductive, genetic, social, and employment concerns following treatment. Communication and coordination of care between the treating oncologist and the primary care clinician is critical to effectively and efficiently manage the long-term care of CRC survivors. The following guidelines are intended to assist primary care clinicians in delivering risk-based health care for CRC survivors who have completed active therapy.

No abstract

Introduction: The American Cancer Society Patient Navigator Program assists high-need, vulnerable patients in overcoming nonmedical barriers to cancer care with the goal of improving treatment adherence, completion, and patient quality of life. Methods: In the last year, the American Cancer Society has been implementing a pilot program aimed at increasing the activation and quality of life of patients at 6 navigation program sites nationwide. The sites were selected based on patient need, geographic location, and cancer center type. Navigators completed a 7-part training series focusing on coaching and communication skills and slight modifications were made to the current lay navigation protocol, including addition of the Insignia Health Patient Activation Measure® (PAM®) Survey, a patient satisfaction survey, formal action planning with the patient, and follow-up on the action plan over a period of at least 3 visits. Results are measured by ability of the patient to achieve the set actions in the plan, ability of the patient to overcome or successfully manage nonmedical barriers to care, and change in the patient's activation score. The following results are from the 3 sites in phase 2 of implementation. Results: After 6 months of implementation, 419 patients have been enrolled in phase 2 of the program. Patients represent 6 different races with African American/Black (40%) and Hispanic/Latino (36%) being most common. Medicaid is the most common form of insurance (42%) and 79% of patients are either insured by Medicaid, Medicare + Medicaid (10%), or uninsured (27%). Patient diagnoses span 32 different cancer types. Early results show positive uptake of the program among navigators and patients with all navigators reporting utilization of new coaching-based training skills, and 95% of patients reporting creating an action plan with their navigator. After their first meeting with the navigator, patients rated their confidence the action plan would work at an average of 8.7/10. Initial patient reactions also indicate a high level of satisfaction with a 4.4/5 average score when asked how much they agreed with the statement: “The navigator made me feel better about my ability to manage my diagnosis and treatment.” 182 patients have completed at least one follow-up visit with the navigator in the first 6 months. These patients set 634 actions with navigators and progress has been made or achieved on 76% of these actions by the first formal follow-up visit. 29 patients have completed the full program with 78% of barriers overcome or successfully managed. 100% of patients completing the program also completed treatment, and the average PAM® score increased by +4.15 points. The project is still ongoing. Final results of the pilot are expected in late 2019. Conclusion: Navigation with coaching and action planning tailored to the patient's activation level is a successful method to assist vulnerable populations with overcoming nonmedical barriers to cancer care and increasing patient activation. Citation Format: Shelby S. Roberts, Dawn Wiatrek, Nicole Erb, Katherine Sharpe. The effects of coaching and action planning on patient activation and quality of life in vulnerable cancer patients [abstract]. In: Proceedings of the Eleventh AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2018 Nov 2-5; New Orleans, LA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(6 Suppl):Abstract nr B038.